New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
07:11 EDTBSXOrbusNeich announces favorable ruling from European Patent Office
OrbusNeich Medical announced that it received a favorable ruling from the European Patent Office yesterday in connection with its European Patent EP1 341 482. The '482 patent covers certain novel stents with helical structures. It was issued by the EPO to OrbusNeich in October 2010 and does not expire until December 2021. In July 2011, Boston Scientific Corporation and Terumo Kabushiki Kaisha filed oppositions asking the EPO to revoke the '482 patent, asserting that the patent was invalid.
News For BSX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 1, 2015
09:01 EDTBSXNevro price target raised to $78 from $65 at JMP Securities
Subscribe for More Information
08:45 EDTBSXNevro more attractive takeover target after patent news, says Sterne Agee CRT
Subscribe for More Information
06:39 EDTBSXNevro patent case win removes possible overhang, says JPMorgan
Subscribe for More Information
November 30, 2015
16:19 EDTBSXBoston Scientific gets FDA appproval, CE Mark for thrombectomy catheter
Subscribe for More Information
16:13 EDTBSXUSPTO denies inter partes review of of Nevro patent
Subscribe for More Information
November 19, 2015
16:43 EDTBSXBoston Scientific receives CE Mark for next generation WATCHMAN FLX
Boston Scientific announced that the first implants of the WATCHMAN FLX Left Atrial Appendage Closure, or LAAC, Device - the latest generation of the WATCHMAN Device - occurred in Europe following CE mark approval.
10:42 EDTBSXLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use